glp-1 receptor agonists effectiveness comparison Comparing GLP-type therapies for weight loss in those without diabetes. Two glucagon-like peptide-1 (GLP-1 RAs) (#semaglutide and #liraglutide) and one dual agonist (#tirzepatide) have been FDA-approved for #weightloss in adults glp 1 dose conversion chart
Description
They were all large-scale trials involving 3,000 to 18,000 patients who were either at high risk of or having established ASCVD, with trial durations ranging from 15 to 60 months
Zepbound : Zepbound uses tirzepatide, which works on two hormone receptors instead of one
Many studies 14 show GLP-1RAs effectively treat cardiovascular conditionslike atherosclerosis and hypertensionin non-diabetic and diabetic groups
Curious about the best GLP-1 drugs for weight loss
It is estimated that approximately 1 in 4 people in the world have NAFLD
The fund is also exposed to cardiometabolic disease more broadly providing a wider vector of growth and innovation
